المؤلفون: Bunch-Barrera, Alfonso, Tamer-David, Layla María, Ardila-Celis, Freddy, Laganis-Valcarcel, Stefano, Castaño-Rodríguez, Ricardo, Vesga-Gualdrón, Jasmin Irene, López-Jaramillo, Patricia, Muñoz, Fabián, Sánchez-Pedraza, Ricardo, Sanabria-Arenas, Rafael Mauricio

المصدر: Revista de la Facultad de Medicina; Vol. 64 Núm. 4 (2016); 695-700 ; Revista de la Facultad de Medicina; Vol. 64 No. 4 (2016); 695-700 ; Revista de la Facultad de Medicina; v. 64 n. 4 (2016); 695-700 ; 2357-3848 ; 0120-0011

مصطلحات موضوعية: Disease Management, Dialysis, Hospitalization, Mortality rate, Medicine, Nefrology, Health sciences, Manejo de la enfermedad, Diálisis, Tasa de mortalidad, Hospitalización, Medicina, Nefrología, Ciencias de la salud

وصف الملف: application/pdf; text/html

Relation: https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/58985; https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/59101; Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney int. 2011;80(12):1258-70. http://doi.org/d3z47w.; de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782-9. http://doi.org/fdp8m4.; Anand S, Nissenson AR. Utilizing a disease management approach to improve ESRD patient outcomes. Semin. Dial. 2002;15(1):38-40. http://doi.org/dfrdzx.; López-Revuelta K, Lorenzo S, Gruss E, Garrido MV, Moreno-Barbas JA. Aplicación de la gestión por procesos en Nefrología. Gestión del proceso de hemodiálisis. Nefrología. 2002;22(4):329-39.; Ramos R, Molina M. Nuevos modelos de gestión de asistencia integral en nefrología. Nefrología. 2013;33(3):301-7.; Nissenson AR, Rettig RA. Medicare’s end-stage renal disease program: current status and future prospects. Health Aff. 1999;18(1):161-79. http://doi.org/cnj89k.; Nissenson AR, Collins AJ, Dickmeyer J, Litchfield T, Mattern W, McMahill CN, et al. Evaluation of disease-state management of dialysis patients. Am. J. kidney Dis. 2001;37(5):938-44. http://doi.org/cm4htm.; Coelho AP, Sá HO, Diniz JA, Dussault G. The integrated management for renal replacement therapy in Portugal. Hemodial. Int. 2014;18(1):175- 84. http://doi.org/bs86.; Saran R, Li Y, Robinson B, Ayanian J, Balkhrishnan R, Bragg- Gresham J, et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2015;66(Suppl 1):S1-305. http://doi.org/bs9b.; Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al. Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial. Transplant 2004;19(1):108-20. http://doi.org/fknh2h.; Castledine C, Davenport A, Dawnay A, Farrington K, Fogarty D, Kumwenda M, et al. UK Renal Registry 2014. 17th Annual Report of the Renal Association. Nephron Clinical Practice. 2015;129(suppl 1).; Marinovich S, Lavorato C, Bisigniano L, Soratti M, Hansen-Krogh D, Celia E, et al. Registro Argentino de Diálisis Crónica SAN-INCUCAI 2011. Buenos Aires: Sociedad Argentina de Nefrología e Instituto Nacional Central Único Coordinador de Ablación e Implante; 2012.; Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de alto costo. Situación de la enfermedad renal crónica, hipertensión arterial y diabetes mellitus en Colombia. Bogotá, D.C.: Cuenta de Alto Costo; 2015 [cited 2016 Nov]. Available from: https://goo.gl/caCIU6.; Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am. J. Kidney Dis. 2003;42(1):125-32. http://doi.org/fxfjrn.; Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. 2003;14(12):3270-77. http://doi.org/bbgknn.; Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, et al. Glycated hemoblobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am. J. Kidney Dis. 2014;63(1):84- 94. http://doi.org/bs9k.; Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, et al. Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients. Clin. Nephrol. 2014;82(3):173- 80. http://doi.org/bs9m.; Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transplant. 2004;19(1):121-32. http://doi.org/br23s4.; Locatelli F, de Francisco A, Deray G, Fliser D, Armnstrong G, Dougherty FC, et al. Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials. Nephron Clin. Pract. 2014;128(3-4):323-32. http://doi.org/bs9r.; Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, et al. Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrol. Dial. Transplant. 2011;26(11):3659-66. http://doi.org/b8cbzs.; Sridhar NR, Josyula S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study. BMC Nephrol. 2013;14:242. http://doi.org/bs9t.; Sakaci T, Ahbap E, Koc Y, Basturk T, Ucar ZA, Sınangıl A, et al. Clinical outcomes and mortality in elderly peritoneal dialysis patients. Clinics.2015;70(5):363-8. http://doi.org/bs9v.; Kramer A, Pippias M, Stel VS, Bonthuis M, Abad-Diez JM, Afentakis N, et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J. 2016;9(3):457-69. http://doi.org/bxds.; Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66(6):2389-401. http://doi.org/fjbpgh.; Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ. Early mortality in patients starting dialysis appears to go unregistered. Kidney Int. 2014;86(2):392-8. http://doi.org/bs9x.; Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM. Early outcomes among those initiating chronic dialysis in the United States. Clin. J. Am. Soc. Nephrol. 2011;6(11):2642-9. http://doi.org/d72bfq.; https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556

الاتاحة: https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556

المؤلفون: Bunch-Barrera, Alfonso, Tamer-David, Layla María, Ardila-Celis, Freddy, Laganis-Valcarcel, Stefano, Castaño-Rodríguez, Ricardo, Vesga-Gualdrón, Jasmin Irene, López-Jaramillo, Patricia, Muñoz, Fabián, Sánchez-Pedraza, Ricardo, Sanabria-Arenas, Rafael Mauricio

مصطلحات موضوعية: 61 Ciencias médicas, Medicina / Medicine and health, Disease Management, Dialysis, Hospitalization, Mortality rate, Manejo de la enfermedad, Diálisis, Tasa de mortalidad, Hospitalización

وصف الملف: application/pdf

Relation: https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556; Universidad Nacional de Colombia Revistas electrónicas UN Revista de la Facultad de Medicina; Revista de la Facultad de Medicina; Bunch-Barrera, Alfonso and Tamer-David, Layla María and Ardila-Celis, Freddy and Laganis-Valcarcel, Stefano and Castaño-Rodríguez, Ricardo and Vesga-Gualdrón, Jasmin Irene and López-Jaramillo, Patricia and Muñoz, Fabián and Sánchez-Pedraza, Ricardo and Sanabria-Arenas, Rafael Mauricio (2016) Impacto de un modelo de gestión de enfermedad en una población con tratamiento de diálisis en Colombia. Revista de la Facultad de Medicina, 64 (4). pp. 695-700. ISSN 2357-3848; https://repositorio.unal.edu.co/handle/unal/65141; http://bdigital.unal.edu.co/66164/

الاتاحة: https://repositorio.unal.edu.co/handle/unal/65141
http://bdigital.unal.edu.co/66164/

Additional Titles: Impacto de un modelo de gestión de enfermedad en una población con tratamiento de diálisis en Colombia

المؤلفون: Bunch-Barrera, Alfonso, Tamer-David, Layla María, Ardila-Celis, Freddy, Laganis-Valcarcel, Stefano, Castaño-Rodríguez, Ricardo, Vesga-Gualdrón, Jasmin Irene, López-Jaramillo, Patricia, Muñoz, Fabián, Sánchez-Pedraza, Ricardo, Sanabria-Arenas, Rafael Mauricio

المصدر: Revista de la Facultad de Medicina; Vol. 64 Núm. 4 (2016); 695-700; Revista de la Facultad de Medicina; Vol. 64 No. 4 (2016); 695-700; Revista de la Facultad de Medicina; v. 64 n. 4 (2016); 695-700; 2357-3848; 0120-0011

مصطلحات الفهرس: Disease Management, Dialysis, Hospitalization, Mortality rate, Medicine, Nefrology, Health sciences, Manejo de la enfermedad, Diálisis, Tasa de mortalidad, Hospitalización, Medicina, Nefrología, Ciencias de la salud, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion, Original research, prospective cohort, Investigación original, Cohorte prospectiva, Investigação original

URL: https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/58985
https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/59101
https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/58985
https://revistas.unal.edu.co/index.php/revfacmed/article/view/54556/59101
*ref*/Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney int. 2011;80(12):1258-70. http://doi.org/d3z47w.
*ref*/de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782-9. http://doi.org/fdp8m4.
*ref*/Anand S, Nissenson AR. Utilizing a disease management approach to improve ESRD patient outcomes. Semin. Dial. 2002;15(1):38-40. http://doi.org/dfrdzx.
*ref*/López-Revuelta K, Lorenzo S, Gruss E, Garrido MV, Moreno-Barbas JA. Aplicación de la gestión por procesos en Nefrología. Gestión del proceso de hemodiálisis. Nefrología. 2002;22(4):329-39.
*ref*/Ramos R, Molina M. Nuevos modelos de gestión de asistencia integral en nefrología. Nefrología. 2013;33(3):301-7.
*ref*/Nissenson AR, Rettig RA. Medicare’s end-stage renal disease program: current status and future prospects. Health Aff. 1999;18(1):161-79. http://doi.org/cnj89k.
*ref*/Nissenson AR, Collins AJ, Dickmeyer J, Litchfield T, Mattern W, McMahill CN, et al. Evaluation of disease-state management of dialysis patients. Am. J. kidney Dis. 2001;37(5):938-44. http://doi.org/cm4htm.
*ref*/Coelho AP, Sá HO, Diniz JA, Dussault G. The integrated management for renal replacement therapy in Portugal. Hemodial. Int. 2014;18(1):175- 84. http://doi.org/bs86.
*ref*/Saran R, Li Y, Robinson B, Ayanian J, Balkhrishnan R, Bragg- Gresham J, et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2015;66(Suppl 1):S1-305. http://doi.org/bs9b.
*ref*/Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al. Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial. Transplant 2004;19(1):108-20. http://doi.org/fknh2h.
*ref*/Castledine C, Davenport A, Dawnay A, Farrington K, Fogarty D, Kumwenda M, et al. UK Renal Registry 2014. 17th Annual Report of the Renal Association. Nephron Clinical Practice. 2015;129(suppl 1).
*ref*/Marinovich S, Lavorato C, Bisigniano L, Soratti M, Hansen-Krogh D, Celia E, et al. Registro Argentino de Diálisis Crónica SAN-INCUCAI 2011. Buenos Aires: Sociedad Argentina de Nefrología e Instituto Nacional Central Único Coordinador de Ablación e Implante; 2012.
*ref*/Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de alto costo. Situación de la enfermedad renal crónica, hipertensión arterial y diabetes mellitus en Colombia. Bogotá, D.C.: Cuenta de Alto Costo; 2015 [cited 2016 Nov]. Available from: https://goo.gl/caCIU6.
*ref*/Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am. J. Kidney Dis. 2003;42(1):125-32. http://doi.org/fxfjrn.
*ref*/Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. 2003;14(12):3270-77. http://doi.org/bbgknn.
*ref*/Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, et al. Glycated hemoblobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am. J. Kidney Dis. 2014;63(1):84- 94. http://doi.org/bs9k.
*ref*/Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, et al. Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients. Clin. Nephrol. 2014;82(3):173- 80. http://doi.org/bs9m.
*ref*/Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transplant. 2004;19(1):121-32. http://doi.org/br23s4.
*ref*/Locatelli F, de Francisco A, Deray G, Fliser D, Armnstrong G, Dougherty FC, et al. Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials. Nephron Clin. Pract. 2014;128(3-4):323-32. http://doi.org/bs9r.
*ref*/Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, et al. Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrol. Dial. Transplant. 2011;26(11):3659-66. http://doi.org/b8cbzs.
*ref*/Sridhar NR, Josyula S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study. BMC Nephrol. 2013;14:242. http://doi.org/bs9t.
*ref*/Sakaci T, Ahbap E, Koc Y, Basturk T, Ucar ZA, Sınangıl A, et al. Clinical outcomes and mortality in elderly peritoneal dialysis patients. Clinics.2015;70(5):363-8. http://doi.org/bs9v.
*ref*/Kramer A, Pippias M, Stel VS, Bonthuis M, Abad-Diez JM, Afentakis N, et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J. 2016;9(3):457-69. http://doi.org/bxds.
*ref*/Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66(6):2389-401. http://doi.org/fjbpgh.
*ref*/Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ. Early mortality in patients starting dialysis appears to go unregistered. Kidney Int. 2014;86(2):392-8. http://doi.org/bs9x.
*ref*/Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM. Early outcomes among those initiating chronic dialysis in the United States. Clin. J. Am. Soc. Nephrol. 2011;6(11):2642-9. http://doi.org/d72bfq.